0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-30M5647
Home | Market Reports | Science| Biological Sciences
Global Methylated RNA Immunoprecipitation Sequencing MeRIP Seq Market Insights Forecast to 2028
BUY CHAPTERS

Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Research Report 2025

Code: QYRE-Auto-30M5647
Report
June 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market

The global market for Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Methylated RNA Immunoprecipitation Sequencing uses sepecific antibodies (m6A, m5C, etc.) to modify the targeted RNAs. After the modification, Immunoprecipitation is then induced to sepecifically enrich & collect those antibody-modified RNAs. Then, use high-throughput sequencing to detect the modified RNAs.
The study of RNA modifications, such as N6-methyladenosine (m6A), has gained significant attention in the fields of molecular biology and genomics. This increased interest in epitranscriptomics has driven demand for techniques like MeRIP-Seq to investigate RNA modifications. MeRIP-Seq has primarily been used in academic and research settings to understand the functional roles of RNA modifications. Research institutions and universities have been key customers for MeRIP-Seq reagents and services. While still in the early stages, there is growing interest in applying MeRIP-Seq and RNA modification analysis to clinical research, including cancer biology and neurological disorders. This presents opportunities for companies to develop diagnostic tools and therapies based on RNA modifications.
This report aims to provide a comprehensive presentation of the global market for Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq).
The Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Report

Report Metric Details
Report Name Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market
Segment by Type
  • Whole Transcriptome Sequencing
  • Incomplete Transcriptome Sequencing
Segment by Application
  • Cell Differentiation Study
  • Developmental Biology Study
  • Disease Development Study
  • Heat Shock Response Study
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Epigentek, Illumina, Merck, Cloudseq Biotech Inc., CD Genomics, Arraystar, LC Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market report?

Ans: The main players in the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market are Epigentek, Illumina, Merck, Cloudseq Biotech Inc., CD Genomics, Arraystar, LC Sciences

What are the Application segmentation covered in the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market report?

Ans: The Applications covered in the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market report are Cell Differentiation Study, Developmental Biology Study, Disease Development Study, Heat Shock Response Study

What are the Type segmentation covered in the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market report?

Ans: The Types covered in the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market report are Whole Transcriptome Sequencing, Incomplete Transcriptome Sequencing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Whole Transcriptome Sequencing
1.2.3 Incomplete Transcriptome Sequencing
1.3 Market by Application
1.3.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cell Differentiation Study
1.3.3 Developmental Biology Study
1.3.4 Disease Development Study
1.3.5 Heat Shock Response Study
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Perspective (2020-2031)
2.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Growth Trends by Region
2.2.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Historic Market Size by Region (2020-2025)
2.2.3 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Region (2026-2031)
2.3 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Dynamics
2.3.1 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Industry Trends
2.3.2 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Drivers
2.3.3 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Challenges
2.3.4 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Players by Revenue
3.1.1 Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Players by Revenue (2020-2025)
3.1.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Players (2020-2025)
3.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue
3.4 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Concentration Ratio
3.4.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue in 2024
3.5 Global Key Players of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Head office and Area Served
3.6 Global Key Players of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq), Product and Application
3.7 Global Key Players of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Breakdown Data by Type
4.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Historic Market Size by Type (2020-2025)
4.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Type (2026-2031)
5 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Breakdown Data by Application
5.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Historic Market Size by Application (2020-2025)
5.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2020-2031)
6.2 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2020-2025)
6.4 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2020-2031)
7.2 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2020-2025)
7.4 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2020-2031)
8.2 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2020-2025)
8.4 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2020-2031)
9.2 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2020-2025)
9.4 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2020-2031)
10.2 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2020-2025)
10.4 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Epigentek
11.1.1 Epigentek Company Details
11.1.2 Epigentek Business Overview
11.1.3 Epigentek Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.1.4 Epigentek Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
11.1.5 Epigentek Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.2.4 Illumina Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.3.4 Merck Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Cloudseq Biotech Inc.
11.4.1 Cloudseq Biotech Inc. Company Details
11.4.2 Cloudseq Biotech Inc. Business Overview
11.4.3 Cloudseq Biotech Inc. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.4.4 Cloudseq Biotech Inc. Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
11.4.5 Cloudseq Biotech Inc. Recent Development
11.5 CD Genomics
11.5.1 CD Genomics Company Details
11.5.2 CD Genomics Business Overview
11.5.3 CD Genomics Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.5.4 CD Genomics Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
11.5.5 CD Genomics Recent Development
11.6 Arraystar
11.6.1 Arraystar Company Details
11.6.2 Arraystar Business Overview
11.6.3 Arraystar Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.6.4 Arraystar Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
11.6.5 Arraystar Recent Development
11.7 LC Sciences
11.7.1 LC Sciences Company Details
11.7.2 LC Sciences Business Overview
11.7.3 LC Sciences Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.7.4 LC Sciences Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
11.7.5 LC Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Whole Transcriptome Sequencing
 Table 3. Key Players of Incomplete Transcriptome Sequencing
 Table 4. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Region (2020-2025)
 Table 8. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Region (2026-2031)
 Table 10. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Trends
 Table 11. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Drivers
 Table 12. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Challenges
 Table 13. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Restraints
 Table 14. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Players (2020-2025)
 Table 16. Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) as of 2024)
 Table 17. Ranking of Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq), Headquarters and Area Served
 Table 20. Global Key Players of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq), Product and Application
 Table 21. Global Key Players of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Type (2020-2025)
 Table 25. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Type (2026-2031)
 Table 27. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Application (2020-2025)
 Table 29. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Application (2026-2031)
 Table 31. North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Epigentek Company Details
 Table 47. Epigentek Business Overview
 Table 48. Epigentek Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
 Table 49. Epigentek Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025) & (US$ Million)
 Table 50. Epigentek Recent Development
 Table 51. Illumina Company Details
 Table 52. Illumina Business Overview
 Table 53. Illumina Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
 Table 54. Illumina Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025) & (US$ Million)
 Table 55. Illumina Recent Development
 Table 56. Merck Company Details
 Table 57. Merck Business Overview
 Table 58. Merck Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
 Table 59. Merck Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025) & (US$ Million)
 Table 60. Merck Recent Development
 Table 61. Cloudseq Biotech Inc. Company Details
 Table 62. Cloudseq Biotech Inc. Business Overview
 Table 63. Cloudseq Biotech Inc. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
 Table 64. Cloudseq Biotech Inc. Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025) & (US$ Million)
 Table 65. Cloudseq Biotech Inc. Recent Development
 Table 66. CD Genomics Company Details
 Table 67. CD Genomics Business Overview
 Table 68. CD Genomics Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
 Table 69. CD Genomics Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025) & (US$ Million)
 Table 70. CD Genomics Recent Development
 Table 71. Arraystar Company Details
 Table 72. Arraystar Business Overview
 Table 73. Arraystar Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
 Table 74. Arraystar Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025) & (US$ Million)
 Table 75. Arraystar Recent Development
 Table 76. LC Sciences Company Details
 Table 77. LC Sciences Business Overview
 Table 78. LC Sciences Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
 Table 79. LC Sciences Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025) & (US$ Million)
 Table 80. LC Sciences Recent Development
 Table 81. Research Programs/Design for This Report
 Table 82. Key Data Information from Secondary Sources
 Table 83. Key Data Information from Primary Sources
 Table 84. Authors List of This Report


List of Figures
 Figure 1. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Picture
 Figure 2. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Type: 2024 VS 2031
 Figure 4. Whole Transcriptome Sequencing Features
 Figure 5. Incomplete Transcriptome Sequencing Features
 Figure 6. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Application: 2024 VS 2031
 Figure 8. Cell Differentiation Study Case Studies
 Figure 9. Developmental Biology Study Case Studies
 Figure 10. Disease Development Study Case Studies
 Figure 11. Heat Shock Response Study Case Studies
 Figure 12. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Report Years Considered
 Figure 13. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Region: 2024 VS 2031
 Figure 16. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Players in 2024
 Figure 17. Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue in 2024
 Figure 19. North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Country (2020-2031)
 Figure 21. United States Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Country (2020-2031)
 Figure 25. Germany Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Region (2020-2031)
 Figure 33. China Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Country (2020-2031)
 Figure 41. Mexico Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Country (2020-2031)
 Figure 45. Turkey Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Epigentek Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
 Figure 49. Illumina Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
 Figure 50. Merck Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
 Figure 51. Cloudseq Biotech Inc. Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
 Figure 52. CD Genomics Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
 Figure 53. Arraystar Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
 Figure 54. LC Sciences Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2020-2025)
 Figure 55. Bottom-up and Top-down Approaches for This Report
 Figure 56. Data Triangulation
 Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart